95849-35-7

Usage

InChI:InChI=1/C11H11NO2/c1-2-9(12-5-1)8-3-4-10-11(6-8)14-7-13-10/h3-4,6H,1-2,5,7H2

Upstream product

• 2635-13-4 1,2-(methylenedioxy)-4-bromobenzene 
• 37673-10-2 2-(Benzo<1,2-d><1,3>dioxol-5-yl)-2-morpholinoacetonitril 
• 120-57-0 piperonal 
• 95877-46-6 2-(Benzo<1,2-d><1,3>dioxolo-5-yl)-4-cyan-2-morpholino-butyronitril 
• 70770-04-6 1-(Benzo<1,2-d><1,3>dioxol-5-yl)-3-cyan-propan-1-on 

Relevant academic research and scientific papers

Iron-Catalyzed Ring Expansion of Cyclobutanols for the Synthesis of 1-Pyrrolines by Using MsONH3OTf

The synthesis of 1-pyrrolines from cyclobutanol derivatives and an aminating reagent (MsONH3OTf) has been developed. This one-pot procedure achieves C–N bond/C═N bond formation via ring expansion. A series of 1-pyrroline derivatives are synthes

Method for synthesizing pyrroline compounds through iron-catalyzed amino alcohol and enol

The invention discloses a method for synthesizing pyrroline compounds through iron-catalyzed amino alcohol and enol. In the atmosphere of inert gas, the amino alcohol and the enol serve as raw materials, potassium tert-butoxide is used as alkali, a series

SUBSTITUTED N-ARYLPYRROLIDINES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS

The present invention provides a compound of the formula: Formula I or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly frailty, osteoporosis, osteopenia, and male and female sexual dysfunction comprising administering to a patient in need thereof an effective amount of a compound of Formula I.